Implementation of a pooled surveillance testing program for asymptomatic SARS-CoV-2 infections in K-12 schools and universities – EClinicalMedicine Related: Pooling of Samples for Testing for SARS-CoV-2 in Asymptomatic People AND Implementation of a Pooled Surveillance Testing Program for Asymptomatic SARS-CoV-2 Infections on a College Campus — Duke University, Durham, North Carolina, August 2–October 11, 2020 […]
The post Study: Pooled saliva analysis is a low-cost and effective strategy for surveillance of Covid-19 in schools and universities and allows to rapidly assess transmission and adjust prevention protocols. appeared first on Links Medicus.
Studies elucidate poorly understood long COVID – CIDRAP
The post Studies elucidate poorly understood long COVID. appeared first on Links Medicus.
CDC warns Covid-19 vaccines might not protect people who are immunocompromised – CNN
The post CDC warns Covid-19 vaccines might not protect people who are immunocompromised – “CDC is looking into ongoing research exploring the possibility that immunocompromised could benefit from an additional dose”. appeared first on Links Medicus.
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact – EClinicalMedicine Commentaries: Identification of over 200 long COVID symptoms prompts call for UK screening programme – University College London AND A survey of long-haulers found 66 symptoms that lasted more than 6 months. Tiredness and brain fog were most common. […]
The post Long Covid: fatigue, post-exertional malaise, and cognitive dysfunction are the most common symptoms, according to an international survey. appeared first on Links Medicus.
Symptoms, complications and management of long COVID: a review – Journal of the Royal Society of Medicine Commentary: Long COVID: More likely in patients with 5+ symptoms in first week of infection – SAGE Publications Commentary on Twitter Pooled prevalence data in this review showed the 10 most prevalent reported symptoms of long covid […]
The post Review: Symptoms, complications and management of long COVID. appeared first on Links Medicus.
Recommendations for use of topical inhalant budesonide in COVID-19 – HNO Related: RCT: Inhaled budesonide shortens recovery time in non-hospitalized patients with COVID-19 AND Phase 2 RCT: Inhaled budesonide shows promise for the treatment of early COVID-19
The post Position Paper: Recommendations for the use of topical inhalant budesonide in COVID-19. appeared first on Links Medicus.
Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection: A Randomized Clinical Trial – JAMA Commentary: Common antibiotic no more effective than placebo in preventing COVID-19 symptoms among non-hospitalized – University of California – San Francisco Related: RCT: Another study shows Azithromycin does not improve outcomes in patients with Covid-19. […]
The post RCT: more data showing Azithromycin is not better than placebo in patients with Covid-19. appeared first on Links Medicus.
Higher versus lower positive end-expiratory pressure in patients without acute respiratory distress syndrome: a meta-analysis of randomized controlled trials – Critical Care
The post M-A of randomized trials: In patients with acute respiratory distress syndrome, there was no difference in mortality between higher vs. lower positive end-expiratory pressure strategies. appeared first on Links Medicus.
Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination – New England Journal of Medicine Related: [Preprint] Mixing Covid jabs has good immune response, study finds – “The Com-Cov trial looked at the efficacy of either two doses of Pfizer, two of AstraZeneca, or one of them followed by the other. All combinations worked well, priming the immune […]
The post Heterologous Oxford–AstraZeneca and Moderna Vaccination induce increased levels of neutralizing antibody compared to 2 doses of Oxford–AstraZeneca. appeared first on Links Medicus.
Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination – Nature Medicine Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination – New England Journal of Medicine Related: [Preprint] Mixing Covid jabs has good immune response, study finds – “The Com-Cov trial looked at the efficacy of either two doses of Pfizer, two of AstraZeneca, […]
The post Heterologous Oxford–AstraZeneca and BioNTech/Pfizer Vaccination induce increased levels of neutralizing antibody compared to 2 doses of Oxford–AstraZeneca. appeared first on Links Medicus.